Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.

Latest updates to the Moderna Press Releases page
- Check5 days agoChange DetectedStock price and trading volume updated from $49.83 (9.26M) to $57.21 (3.54M).SummaryDifference0.5%

- Check13 days agoChange DetectedAdded new press releases to the News section, including Moderna Resolves Global Patent Litigation with Arbutus/Genevant and other February–March 2026 updates.SummaryDifference7%

- Check20 days agoChange DetectedStock price and volume figures were updated, and new press releases were added (including Moderna to Present at Upcoming Conferences in March 2026 and FDA review initiation). Older January 2026 press releases were removed.SummaryDifference5%

- Check27 days agoChange DetectedNew press releases were added to the News and Blog Posts list: 'Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates' (February 13, 2026) and 'Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE' (February 17, 2026). The stock data values in the header were updated.SummaryDifference1%

- Check34 days agoChange DetectedStock price and volume were updated from $42.20 / 9.36M to $41.99 / 9.99M. Two new press releases were added: 'Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico' and 'Moderna Receives Refusal-to-File Letter from the FDA for Its Investigational Seasonal Influenza Vaccine, mRNA-1010'.SummaryDifference2%

- Check41 days agoChange DetectedTwo new press releases were added to the News and Blog Posts list, including Dr. David Berman joining Moderna as Chief Development Officer and a strategic collaboration with Recordati. The top stock quote updated from $45.45 (15.24M) to $42.20 (9.36M).SummaryDifference2%

Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.